Beckman Coulter Inc has expanded its drugs of abuse test menu to include a Buprenorphine Enzyme Immunoassay. The test provides fast screening for the qualitative and semi-quantitative determination of norbuprenorphine (buprenorphine metabolite) in human urine.
Reagents and calibrators for the assay are liquid and ready-to-use, eliminating the need to mix, hydrate or pre-dilute reagents before testing. The assay’s cutoff value is 10 ng/mL for norbuprenorphine, and it delivers analytical sensitivity of 3 ng/mL for buprenorphine and norbuprenorphine (the active, dealkylated metabolite of buprenorphine). It cross-reacts at 94% with buprenorphine.
Drugs of Abuse Test (DAT) assays, available through Beckman Coulter, are formulated to deliver the critical elements of effective DAT analysis — speed, accuracy, ease-of-use and economy. When used in conjunction with Synchron,® UniCel® Clinical Chemistry Systems and i class Integrated Systems, these high quality assays provide timely, reliable and efficient DAT results.
Source: Beckman Coulter
